144 related articles for article (PubMed ID: 29770475)
1. Improvement in facial discoid dermatosis with calcipotriol/betamethasone ointment and low-dose acitretin.
Bohdanowicz M; DeKoven JG
Clin Exp Dermatol; 2018 Oct; 43(7):820-821. PubMed ID: 29770475
[No Abstract] [Full Text] [Related]
2. Grover's disease: successful treatment with acitretin and calcipotriol.
Miljković J; Marko PB
Wien Klin Wochenschr; 2004; 116 Suppl 2():81-3. PubMed ID: 15506319
[TBL] [Abstract][Full Text] [Related]
3. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis.
van de Kerkhof PC; Cambazard F; Hutchinson PE; Haneke E; Wong E; Souteyrand P; Damstra RJ; Combemale P; Neumann MH; Chalmers RJ; Olsen L; Revuz J
Br J Dermatol; 1998 Jan; 138(1):84-9. PubMed ID: 9536227
[TBL] [Abstract][Full Text] [Related]
4. Acrodermatitis continua of Hallopeau: response to combined treatment with acitretin and calcipotriol ointment.
Kuijpers AL; van Dooren-Greebe RJ; van de Kerkhof PC
Dermatology; 1996; 192(4):357-9. PubMed ID: 8864375
[TBL] [Abstract][Full Text] [Related]
5. Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison.
Pagliarello C; Fabrizi G; Fantini C; Cortelazzi C; Boccaletti V; Annessi G; Zampetti A; Feliciani C; Di Nuzzo S
Eur J Dermatol; 2015 Apr; 25(2):206-8. PubMed ID: 25786341
[No Abstract] [Full Text] [Related]
6. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
[TBL] [Abstract][Full Text] [Related]
8. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
[No Abstract] [Full Text] [Related]
9. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
Poulin Y
Skin Therapy Lett; 2002 Jun; 7(6):1-3. PubMed ID: 12223976
[TBL] [Abstract][Full Text] [Related]
10. Persistent facial discoid dermatosis successfully treated with topical calcipotriol.
Amarnani R; Hughes S; Morris-Jones R; Kanwar AJ; Bunker CB
Clin Exp Dermatol; 2022 Jan; 47(1):229-231. PubMed ID: 34648653
[No Abstract] [Full Text] [Related]
11. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
McCormack PL
Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
[TBL] [Abstract][Full Text] [Related]
12. VDR gene polymorphisms are associated with the clinical response to calcipotriol in psoriatic patients.
Zhao Y; Chen X; Li J; He Y; Su J; Chen M; Zhang W; Chen W; Zhu W
J Dermatol Sci; 2015 Sep; 79(3):305-7. PubMed ID: 26169344
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of simple onycholysis: an open-label study.
Park JM; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim BS; Kim MB
J Am Acad Dermatol; 2013 Sep; 69(3):492-3. PubMed ID: 23957979
[No Abstract] [Full Text] [Related]
14. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
[TBL] [Abstract][Full Text] [Related]
15. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Katz HI
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and systemic therapy.
van de Kerkhof P
Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
[TBL] [Abstract][Full Text] [Related]
17. Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment.
Abramovits W; Perlmutter A; Gupta AK
Skinmed; 2006; 5(3):136-8. PubMed ID: 16687982
[No Abstract] [Full Text] [Related]
18. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo.
Newman MD; Silverberg NB
Cutis; 2011 Nov; 88(5):256-9. PubMed ID: 22272490
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of Prurigo nodularis.
Wong SS; Goh CL
Arch Dermatol; 2000 Jun; 136(6):807-8. PubMed ID: 10871962
[No Abstract] [Full Text] [Related]
20. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Calzavara-Pinton P; Rossi MT; Sala R; Venturini M
G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
